SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 on a Randomized Phase II PACE (Palbociclib After CDK4/6i & ET) Study: Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-Treated ER+/HER2- mBC
By
SABCS 2022 Conference Coverage
FEATURING
Erica Mayer
By
SABCS 2022 Conference Coverage
FEATURING
Erica Mayer
333 views
December 13, 2022
Comments 0
Login to view comments.
Click here to Login
Videos